Raymond James Trust N.A. raised its holdings in Envista Holdings Co. (NYSE:NVST – Free Report) by 3.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,959 shares of the company’s stock after buying an additional 1,072 shares during the quarter. Raymond James Trust N.A.’s holdings in Envista were worth $482,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Van Lanschot Kempen Investment Management N.V. boosted its position in Envista by 32.9% during the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,936,916 shares of the company’s stock valued at $48,841,000 after acquiring an additional 727,406 shares in the last quarter. Hedges Asset Management LLC purchased a new position in shares of Envista in the 2nd quarter valued at approximately $532,000. Shayne & Jacobs LLC boosted its position in shares of Envista by 12.0% during the second quarter. Shayne & Jacobs LLC now owns 62,600 shares of the company’s stock valued at $1,041,000 after purchasing an additional 6,700 shares in the last quarter. Leeward Investments LLC MA grew its stake in Envista by 1.1% in the second quarter. Leeward Investments LLC MA now owns 640,589 shares of the company’s stock worth $10,653,000 after purchasing an additional 6,982 shares during the period. Finally, Raymond James & Associates raised its holdings in Envista by 22.6% in the second quarter. Raymond James & Associates now owns 1,032,350 shares of the company’s stock worth $17,168,000 after purchasing an additional 190,240 shares in the last quarter.
Insiders Place Their Bets
In other news, CFO Eric D. Hammes purchased 24,532 shares of the stock in a transaction dated Monday, August 12th. The shares were purchased at an average cost of $16.33 per share, with a total value of $400,607.56. Following the acquisition, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.
Analyst Ratings Changes
Get Our Latest Research Report on NVST
Envista Trading Down 1.5 %
Shares of NYSE:NVST opened at $18.42 on Tuesday. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.27 and a quick ratio of 1.93. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $33.25. The company has a market cap of $3.17 billion, a P/E ratio of -25.58, a PEG ratio of 14.74 and a beta of 1.31. The stock’s fifty day moving average price is $16.72 and its 200-day moving average price is $18.98.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a negative net margin of 4.70% and a positive return on equity of 5.84%. The company had revenue of $633.10 million for the quarter, compared to analysts’ expectations of $646.88 million. During the same period in the previous year, the business earned $0.43 EPS. The business’s revenue was down 4.4% compared to the same quarter last year. Sell-side analysts expect that Envista Holdings Co. will post 1.15 earnings per share for the current year.
Envista Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- How to Start Investing in Real Estate
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- When to Sell a Stock for Profit or Loss
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.